Prophase Labs Stock Investor Sentiment
| PRPH Stock | USD 0.18 0.03 20.00% |
Under 63% of all ProPhase Labs' traders are looking to take a long position. The analysis of overall sentiment of trading ProPhase Labs stock suggests that some investors are interested at this time. ProPhase Labs' investing sentiment shows overall attitude of investors towards ProPhase Labs.
ProPhase Labs Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ProPhase Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors may consider stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
BC-Most Active Stocks
recently @ finance.yahoo.com
Note that negative investor sentiment can cause investors to consider selling stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of ProPhase Labs' Stock prices. Below is the latest headlines and news related to ProPhase Labs Stock. The global stock market is bullish. About 62% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. This information is accessible both publicly - through ProPhase Labs' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of ProPhase-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.
ProPhase Largest EPS Surprises
Earnings surprises can significantly impact ProPhase Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2004-10-28 | 2004-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
1997-08-13 | 1997-06-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2010-11-10 | 2010-09-30 | 0.09 | 0.06 | -0.03 | 33 | ||
2000-10-26 | 2000-09-30 | -0.02 | 0.01 | 0.03 | 150 | ||
1998-10-30 | 1998-09-30 | 0.23 | 0.2 | -0.03 | 13 | ||
2025-08-13 | 2025-06-30 | -0.15 | -0.11 | 0.04 | 26 |
There is far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. This information is accessible both publicly - through ProPhase Labs' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of ProPhase-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.
ProPhase Labs Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Sykon Capital LLC Acquires Shares of 644,795 ProPhase Labs, Inc. PRPH | 11/17/2025 |
2 | Acquisition by Ted Karkus of 500000 shares of ProPhase Labs at 0.6 subject to Rule 16b-3 | 11/21/2025 |
3 | Prophase Labs Secures Forbearance Agreement with Avtech Capital - TipRanks | 11/25/2025 |
4 | Prophase Labs Faces Unsealed Civil Action Disclosure - MSN | 12/15/2025 |
5 | 12 Health Care Stocks Moving In Fridays Pre-Market Session | 01/02/2026 |
6 | ProPhase Labs Updates Shareholders Amid Volatility and OTC Move - TipRanks | 01/09/2026 |
7 | ProPhase Labs Uplists from Pink Sheets to OTC Market | 01/22/2026 |
8 | ProPhase Labs Provides Crown Medical Collections Update 250 Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture | 01/26/2026 |
9 | Acquisition by Ted Karkus of 600000 shares of ProPhase Labs at 0.6 subject to Rule 16b-3 | 01/29/2026 |
10 | ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart and Advances Crown Medical Collections Initiative | 02/03/2026 |
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets |